WGSWW
GeneDx Holdings Corp.NASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
2.07
52W High
$0.13
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-17.60%
Forward P/E
—
PEG Ratio
—
About GeneDx Holdings Corp.
GeneDx Holdings Corp. (Ticker: WGSWW) is a pioneering force in the genomics industry, focusing on genomic testing and precision medicine to diagnose rare and challenging genetic conditions. Leveraging state-of-the-art sequencing technologies and a robust genetic knowledge database, GeneDx empowers healthcare providers with critical diagnostic tools that shape effective treatment plans. Its comprehensive suite of genetic testing services, coupled with strategic alliances in the healthcare ecosystem, positions the company advantageously within a competitive landscape, reflecting its dedication to advancing personalized medicine and improving patient outcomes through innovative genetic healthcare solutions.
Fundamentals
| Revenue (TTM) | $442.68M |
| Gross Profit (TTM) | $307.91M |
| EBITDA | $-7.85M |
| Operating Margin | -25.60% |
| Return on Equity | -30.40% |
| Return on Assets | -4.37% |
| Revenue/Share (TTM) | $15.30 |
| Book Value | $10.54 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 17.40% |
| Shares Outstanding | 0 |
| Float | $19.31M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/25/2026